Skip to content

PharmaDEXI: what changed

BE 0771.461.685Other company

Position among the sector peers

What moved between 2022 and 2023

Net result for the year
-€14,540
2022 · -€30,616+€16,075
Equity
-€40,156
2022 · -€25,616-€14,540
Cash
€1,648
2022 · -+€1,648
Balance sheet total
€29,457
2022 · €31,477-€2,021

Largest movements

2022 to 2023
Assets
  • Intangible fixed assets -€2,817

    down €2,817 (-14.6%), from €19,254 to €16,437

  • Cash +€1,648

    first reported in 2023, at €1,648

    mainly Other debts (+€18,875) and Depreciation (+€2,817)

  • Receivables within one year -€851

    down €851 (-7.5%), from €11,323 to €10,472

    of which Other amounts receivable: -€1,855

Equity and liabilities
  • Other debts +€18,875

    up €18,875 (+49.3%), from €38,315 to €57,190

  • Profit (loss) carried forward -€14,540

    down €14,540 (-47.5%), from -€30,616 to -€45,156

  • Short-term financial debts -€4,510

    no longer reported in 2023; in 2022 it stood at €4,510

  • Trade debts -€1,016

    down €1,016 (-7.6%), from €13,438 to €12,422

  • Advances received -€830

    no longer reported in 2023; in 2022 it stood at €830

Income statement
  • Depreciation -€11,741

    down €11,741 (-80.6%), from €14,559 to €2,817

  • Gross operating margin +€6,666

    up €6,666 (+41.9%), from -€15,918 to -€9,252

  • Other operating charges +€2,328

    up €2,328 (+3,751%), from €62 to €2,390

Change in the result, 2022 to 2023

effect on the result

For each income-statement line you see the change as its effect on the result.

Result 2022 -€30,616
Gross operating margin +€6,666
Depreciation +€11,741
Other operating charges -€2,328
Financial charges -€4
Result 2023 -€14,540
raises the resultlowers the result

Derived cash bridge

cash 2022 to 2023

The bridge is derived from the 2022 and 2023 balance sheets and the 2023 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€6,158
Investment €0
Financing -€4,510
Cash 2022 €0
Net result for the year -€14,540
Depreciation +€2,817
Receivables within one year +€851
Trade debts -€1,016
Advances received -€830
Other debts +€18,875
Short-term financial debts -€4,510
Cash 2023 €1,648
brings cash intakes cash out
Every line side by side 30 lines
Line Code 2022 2023 Change %
Total assets 20/58 €31,477 €29,457 -€2,021 -6.4%
Fixed assets 21/28 €20,154 €17,337 -€2,817 -14.0%
Intangible fixed assets 21 €19,254 €16,437 -€2,817 -14.6%
Financial fixed assets 28 €900 €900 = 0.0%
Current assets 29/58 €11,323 €12,120 +€797 +7.0%
Amounts receivable within one year 40/41 €11,323 €10,472 -€851 -7.5%
Trade receivables 40 €9,155 €10,159 +€1,004 +11.0%
Other amounts receivable 41 €2,168 €313 -€1,855 -85.6%
Cash at bank and in hand 54/58 - €1,648 +€1,648
Total equity and liabilities 10/49 €31,477 €29,457 -€2,021 -6.4%
Equity 10/15 -€25,616 -€40,156 -€14,540 -56.8%
Contributions 10/11 €5,000 €5,000 = 0.0%
Profit (loss) carried forward 14 -€30,616 -€45,156 -€14,540 -47.5%
Amounts payable 17/49 €57,093 €69,612 +€12,520 +21.9%
Amounts payable within one year 42/48 €57,093 €69,612 +€12,520 +21.9%
Financial debts 43 €4,510 - -€4,510
Credit institutions 430/8 €4,510 - -€4,510
Trade debts 44 €13,438 €12,422 -€1,016 -7.6%
Suppliers 440/4 €13,438 €12,422 -€1,016 -7.6%
Advances received on contracts in progress 46 €830 - -€830
Other amounts payable 47/48 €38,315 €57,190 +€18,875 +49.3%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €14,559 €2,817 -€11,741 -80.6%
Other operating charges 640/8 €62 €2,390 +€2,328 +3,751%
Gross operating margin 9900 -€15,918 -€9,252 +€6,666 +41.9%
Operating profit (loss) 9901 -€30,539 -€14,459 +€16,079 +52.7%
Financial charges 65/66B €77 €81 +€4 +5.2%
Recurring financial charges 65 €77 €81 +€4 +5.2%
Profit (loss) for the period before taxes 9903 -€30,616 -€14,540 +€16,075 +52.5%
Profit (loss) for the period 9904 -€30,616 -€14,540 +€16,075 +52.5%
Profit (loss) for the period to be appropriated 9905 -€30,616 -€14,540 +€16,075 +52.5%

Value

latest balance sheet 31-12-2023 · indication, not a valuation or advice

Value of the equity

Indication, not a valuation or advice

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate. Change the assumptions and the value follows.

The filed figures and these assumptions give no positive value. The adjusted equity and the average result are both zero or negative.

Part of the calculation comes out below zero. A shareholding is never worth less than zero, so the floor is zero.

Adjusted equity -€56,592

Adjusted equity

balance sheet 31-12-2023
Equity (10/15)
-€40,156
Intangible fixed assets (21)
-€16,437
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
-€56,592

Capitalised earnings

net result for the year (9904)
2023
-€14,540
2022
-€30,616
Average result
-€22,578
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
not meaningful, as the average result is zero or negative

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2022 and 31 December 2023. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 21 November 2026 via checked.be.